Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial Treatment With Methotrexate in LGL Leukemia
NCT00003910Phase 2Terminated
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Sep 1999
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of methotrexate in large granular lymphocytic leukemia (LGLL), sponsored by Eastern Cooperative Oncology Group. Primary endpoint: Proportion of Patients With Complete or Partial Response to Treatment With MTX at 5 years. Started Sep 1999; status: terminated.
02
Drugs
methotrexate
03
Conditions
large granular lymphocytic leukemia (LGLL)
Beyond the preview
Go deeper on NCT00003910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003910.